Adagene Inc.
ADAG$248M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaJIANGSU138 employees
Drugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Oct 2026
Market Overview
Stock performance and key metrics
ADAG News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
ADG126 Mono | Phase 2 | Advanced/Metastatic Solid Tumors | - | - |
ADG126 | Phase 2 | Advanced/Metastatic Solid Tumors | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply